Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AF Ablation Lacks Evidence, Despite Growing Adoption – TEC Assessment

This article was originally published in The Gray Sheet

Executive Summary

A recent BlueCross BlueShield Association assessment of atrial fibrillation ablation echoes widespread belief among payors and doctors that the technique is still evolving
Advertisement

Related Content

Catheter Ablation “Reasonable” For Atrial Fibrillation When Drugs Fail - ACC
Catheter Ablation “Reasonable” For Atrial Fibrillation When Drugs Fail - ACC
Study Reports Strong Results For Atrial Fibrillation Treatment With Ablation
St. Jude Looks Beyond ICDs To Emerging AF Market For Growth In 2006
St. Jude Looks Beyond ICDs To Emerging AF Market For Growth In 2006
Top Electrophysiologists Assess AF Balloon Ablation Devices
Advertisement
UsernamePublicRestriction

Register

MT023609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel